Eli Lilly clinical study into antibody drug against coronavirus

On this edition of the podcast you’ll hear the latest on Crown Point Mayor Dave Uran testing positive for COVID-19, Bárbara Anguiano reports on Johnson and Johnson resuming its vaccine trials in the Region, and Chris Nolte has a conversation with Burgess Peoples, the president and chief strategist for the City of Gary’s Faith Leaders and Community Partnerships. All of that, and more, on this edition of “Lakeshore Update”…

On this edition of the podcast you’ll hear the latest on Hammond student-athletes returning to fall contact sports following an August cancellation due to the coronavirus pandemic, Samantha Horton reports Eli Lily says it’s COVID-19 antibody drug is showing results in reducing hospitalizations from the virus and Chris Nolte has a conversation with NWI financial advisor Greg Hammer. He offers tips to reduce “pandemic panic” while planning for retirement. All of that, and more, on this edition of “Lakeshore Update”… 

Today:   Robert Blaszkiewicz with Franciscan Health here in northwest Indiana joins us to talk about, among other topics, the participation of the Hammond facility  in an Eli Lilly clinical study evaluating the safety and effectivemess of an antibody treatment drug for early-stages of the coronavirus. He also tells about how the latest thermal scanning technology is being used to screen visitors to all of its facilities.  We bring back our conversation with Big Shoulders Fund CEO Josh Hale about the work the organization is doing with the Diocese of Gary schools. And Purdue University biomedical engineering professor Young Kim talks about how he and his research team are developing an airborne disinfection method -- using edible food coloring dyes -- that could be an effective sterilization process in the fight against COVID-19.